Elevai Labs Inc. develops biopharmaceutical treatments and regenerative skincare applications that target skin aesthetics and metabolic health issues. Their portfolio includes specialized subsidiaries focused on medical aesthetics and drug development, providing effective solutions for obesity-related skin conditions.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals experience skin aesthetic and metabolic health issues, including obesity-related skin conditions, which can be difficult to treat with conventional methods. Current solutions may not effectively address the underlying causes or provide comprehensive regenerative benefits.
Solution
Elevai Labs Inc. develops biopharmaceutical treatments and regenerative skincare applications targeting skin aesthetics and metabolic health issues. Through its specialized subsidiaries, the company focuses on medical aesthetics and drug development to provide effective solutions for obesity-related skin conditions. Elevai Skincare Inc., Elevai Biosciences Inc., and Elevai Research Inc. work synergistically to innovate and deliver advancements in both medical aesthetics and biopharmaceutical sectors. The company aims to provide comprehensive solutions that address the root causes of skin and metabolic health issues, offering regenerative benefits.
Target Audience
The primary customers are individuals seeking advanced treatments for skin aesthetic and metabolic health issues, as well as medical professionals in the aesthetics and biopharmaceutical fields.
Features
- Biopharmaceutical drug development for metabolic health issues
- Regenerative skincare applications targeting skin aesthetics
- Specialized subsidiaries focused on medical aesthetics and drug development
- Solutions for obesity-related skin conditions